Celgene's Lung Cancer Drug Gets FDA 'Fast Track' Approval
By Shankar P.
9/4/2008


Celgene Corp. (Nasdaq: CELG), a pharmaceutical company based in Summit, today announced that its lung cancer drug, "Amrubicin," has been granted "fast track" approval by the U.S. Food and Drug Administration. Amrubicin is for the treatment of small cell lung cancer after chemotherapy, the company said in a statement.
The FDA grants "fast track" designation for a drug that treats "a serious or life-threatening condition," Celgene said. Drugs with fast-track designations could potentially get expedited regulatory approvals, according to the company.

Small cell lung cancer is a disease in which malignant cells form in the tissues of the lung; it occurs almost exclusively in people who smoke, Celgene said.

_________________
April/03 My Wife Deborah, age 46, diagnosed adenocarcinoma NSCLC
1/20/2006 Admitted to hospital Respiratory distress
1/23/2006 Ran to the light and is waiting for us to be rejoined in the Kingdom Of Heaven Her journey is Over but mine lingers on for Now!!!
4/23/07 DEb is joined in Peace by her Puppy Dawg Daisy from Cancer
8/30/07 Got new Pup named Mocha!!

"No matter hnow much it hurts, No matter how alone you feel, Your friends will help you get through anything!!"
Scrubs!!!!Yes the comedy show!!!

The Reason I advocate
If you would like to see our family photos Click on this link!
http://deborah-wallin.memory-of.com/

My memory-of Link is good to go now if you want to see it!!